Kempen Capital Management N.V. Johnson & Johnson Transaction History
Kempen Capital Management N.V.
- $8.8 Billion
- Q2 2024
A detailed history of Kempen Capital Management N.V. transactions in Johnson & Johnson stock. As of the latest transaction made, Kempen Capital Management N.V. holds 855,403 shares of JNJ stock, worth $134 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
855,403
Previous 732,915
16.71%
Holding current value
$134 Million
Previous $116 Million
7.84%
% of portfolio
1.42%
Previous 1.46%
Shares
17 transactions
Others Institutions Holding JNJ
# of Institutions
4,227Shares Held
1.7BCall Options Held
12.5MPut Options Held
10.3M-
Vanguard Group Inc Valley Forge, PA229MShares$35.9 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY198MShares$31.1 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$20.9 Billion0.86% of portfolio
-
Geode Capital Management, LLC Boston, MA55.1MShares$8.64 Billion0.72% of portfolio
-
Morgan Stanley New York, NY42.1MShares$6.59 Billion0.48% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $410B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...